XML 22 R8.htm IDEA: XBRL DOCUMENT v2.4.0.6
CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) (USD $)
6 Months Ended
Sep. 30, 2012
Sep. 30, 2011
Cash flow from operating activities:    
Net income $ 45,516,447 $ 43,486,022
Adjustments to reconcile net income to net cash provided by operating activities:    
Amortization of intangible assets 707,720 866,997
Amortization of loan costs and discounts 431,437 248,462
Provision for loan losses 56,016,554 52,896,383
Amortization of convertible note discount 0 1,819,600
Depreciation 3,083,921 3,210,782
Deferred income tax benefit (7,130,570) (3,786,627)
Compensation related to stock option and restricted stock plans 3,810,220 3,070,440
Unrealized gains on interest rate swap 0 (210,260)
Change in accounts:    
Other assets, net (292,766) 1,162,445
Income taxes payable (4,963,192) (2,392,532)
Accounts payable and accrued expenses (2,985,014) (2,468,123)
Net cash provided by operating activities 94,194,757 97,903,589
Cash flows from investing activities:    
Increase in loans receivable, net (123,603,259) (109,594,808)
Net assets acquired from office acquisitions, primarily loans (1,045,264) (1,794,118)
Increase in intangible assets from acquisitions (361,061) (386,991)
Purchases of property and equipment (3,939,867) (3,474,906)
Net cash used in investing activities (128,949,451) (115,250,823)
Cash flow from financing activities:    
Proceeds from senior revolving notes payable, net 157,350,000 150,350,000
Increase in restricted cash 0 (77,000,000)
(Payments on)/proceeds from junior subordinated note payable (50,000,000) 20,000,000
Proceeds from exercise of stock options 3,355,695 2,070,760
Repurchase of common stock (75,141,185) (73,062,561)
Excess tax benefits from exercise of stock options 1,099,228 462,974
Net cash provided by financing activities 36,663,738 22,821,173
Increase in cash and cash equivalents 1,909,044 5,473,939
Effects of foreign currency fluctuations on cash 27,145 (443,616)
Cash and cash equivalents at beginning of period 10,768,176 8,030,580
Cash and cash equivalents at end of period $ 12,704,365 $ 13,060,903